Research ArticleArticle
Biotransformation of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, in Dogs, Rats, and Humans, In Vivo and In Vitro
Michael Gerisch, Roland Heinig, Anna Engelen, Dieter Lang, Peter Kolkhof, Martin Radtke, Johannes Platzek, Kai Lovis, Gabriele Rohde and Thomas Schwarz
Drug Metabolism and Disposition September 4, 2018, dmd.118.083337; DOI: https://doi.org/10.1124/dmd.118.083337
Michael Gerisch
Bayer AG
Roland Heinig
Bayer AG
Anna Engelen
Bayer AG
Dieter Lang
Bayer AG
Peter Kolkhof
Bayer AG
Martin Radtke
Bayer AG
Johannes Platzek
Bayer AG
Kai Lovis
Bayer AG
Gabriele Rohde
Bayer AG
Thomas Schwarz
Bayer AG
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Biotransformation of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, in Dogs, Rats, and Humans, In Vivo and In Vitro
Michael Gerisch, Roland Heinig, Anna Engelen, Dieter Lang, Peter Kolkhof, Martin Radtke, Johannes Platzek, Kai Lovis, Gabriele Rohde and Thomas Schwarz
Drug Metabolism and Disposition September 4, 2018, dmd.118.083337; DOI: https://doi.org/10.1124/dmd.118.083337
Research ArticleArticle
Biotransformation of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, in Dogs, Rats, and Humans, In Vivo and In Vitro
Michael Gerisch, Roland Heinig, Anna Engelen, Dieter Lang, Peter Kolkhof, Martin Radtke, Johannes Platzek, Kai Lovis, Gabriele Rohde and Thomas Schwarz
Drug Metabolism and Disposition September 4, 2018, dmd.118.083337; DOI: https://doi.org/10.1124/dmd.118.083337
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement